Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the […]

Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the

Of Clones and Clowns A distinguished molecular biologist discusses the “cloning circus” and the damage it is doing to serious

Legal Circumvention Molecular switches provide a route around existing gene patents

5 Big Drug Companies Face R&D Drought Five of the world’s biggest drug companies do not have any potential billion-dollar

5 Big Drug Companies Face R&D Drought Five of the world’s biggest drug companies do not have any potential billion-dollar

Informatics Moves to the Head of the Class The race is on to increase the quantity and quality of bio-IT

Nanopharmaceuticals Open Up Brand New Field Of Study Drug-binding molecules tiny enough to travel through the body’s smallest capillaries may

Networked Pharma The pharmaceutical industry is experiencing a deepening productivity crisis. The industry’s preferred escape mechanism from this predicament has

Pharma Financial Squeeze Bodes Ill for Genomics ‘Caution: Tougher Times Ahead’ may be an apt sign for biotech in general